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Objective: Omega-3 fatty acids, especially alpha-linolenic acid (ALA), which are present in nuts may
reduce cardiovascular disease (CVD) risk, by changing vascular inﬂammation and improving endothelial
dysfunction. The objective of the study was to evaluate the acute effects of two different diets, one
containing walnuts and the other almonds on endothelial function.
Methods: Twenty-seven overweight volunteers underwent a randomized 2-period, crossover, controlled
intervention study. The subjects were given either walnut or almond diets which varied in
monounsaturated fatty acid (MUFA) and polyunsaturated fatty acid (PUFA) content. The walnut diet
provided 23.1% energy from PUFA and the almond diet provided 7.6% energy from PUFA. Endothelial
function was assessed physiologically by ﬂow-mediated dilation (FMD) and biochemically by sVCAM
(soluble vascular cell adhesion molecules).
Results: The walnut diet signiﬁcantly improved FMD (p = 0.004) and decreased sVCAM (p = 0.009)
whereas the almond diet tended to improve FMD (p = 0.06) and signiﬁcantly decreased sVCAM
(p = 0.004).
Conclusion: Both walnut and almond diets improved FMD and sVCAM and there was no signiﬁcant
difference in physiological and biochemical markers between the two diets.
© 2018 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. Introduction
Endothelial dysfunction is an early event in the development of
atherosclerotic vascular disease.1,2 Recent studies indicate that
coronary endothelial dysfunction predicts future cardiovascular
disease (CVD) events.3–5 Endothelial function can be assessed
noninvasively in the peripheral circulation by brachial artery
ultrasound and it correlates well with coronary artery endothelial
function.6–8
Walnuts differ from all other nuts by a high content of alphalinolenic acid (ALA), a vegetable n-3 fatty acid, which might confer
additional anti-atherogenic properties.9–11 Replacement of fatty

* Corresponding author at: PO Box 9157, Section of Cardiology, Department of
Medicine, West Virginia University, Morgantown, WV-26506, USA.
E-mail address: ravindrabhardwaj2002@yahoo.com (R. Bhardwaj).

foods in the diet with nuts reduces blood cholesterol and has other
beneﬁcial effects on the cardiovascular risk proﬁle.12–15 Monounsaturated fatty acids (MUFA), mainly oleic acid, is predominant in
almonds while walnuts are rich in polyunsaturated fatty acids
(PUFA) like linoleic acid and ALA. Walnuts have a higher amount of
n-6 and n-3 fatty acids as compared to almonds. Also, the n-6/n-3
ratio is lower in walnuts. A lower ratio of n-6/n-3 fatty acids is more
desirable in reducing the risk of many of the chronic diseases.16 The
fatty acids from nuts have a beneﬁcial effect on the cardiovascular
system such as lowering blood cholesterol, reducing vascular
inﬂammation and improving endothelial function.10,17,18
Various studies have assessed endothelial function and
inﬂammatory markers after supplementing diets with almonds
or walnuts separately.19–23 However none of the studies have
investigated the acute effect of a diet rich in both almonds and
walnuts on the endothelium.

https://doi.org/10.1016/j.ihj.2018.01.030
0019-4832/© 2018 Published by Elsevier B.V. on behalf of Cardiological Society of India. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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with a blood sample taken at 3:30 PM and a second endothelial
function test at 4:00 PM after resting for half an hour. Previous
studies have shown that 4 h is sufﬁcient time to evaluate the acute
effect of nuts.21 Also, the largest changes in triglycerides and
endothelial function have been observed 3–4 h postprandially.24,25
During the 4-h interval, participants rested in a quiet room and were
allowed to drink water.
The end points were the between-diet differences in changes
from baseline of ﬂow-mediated dilation (FMD) assessed as the
percentage change in brachial artery diameter during reactive
hyperemia and postprandial changes in FMD and plasma concentrations of soluble vascular cell adhesion molecules (sVCAM).

To test the hypothesis that walnut intake (high PUFA content)
would improve endothelial function compared to almond intake
(high MUFA content), we performed a randomized, crossover
feeding trial with a walnut-enriched diet and compared it with an
almond-enriched diet to access the brachial artery vasomotor
function and a circulating marker of endothelial activation in over
weight subjects.
2. Subjects and methods
2.1. Subjects
Twenty-seven asymptomatic over weight individuals (BMI
> 25 kg/m2) were recruited into a protocol approved by the
institutional review board and gave informed consent. Of the 27
participants in the study, 16 were women and 11 were men. All
participants were non-smokers, had normal blood pressure and
took no medications or antioxidant supplements. Health status of
the subjects was evaluated by questionnaire. Subjects that did not
ﬁt the study criteria were excluded by questionnaire. Exclusion
criteria included subjects with diabetes, coronary artery disease,
allergy to nuts (walnuts and almonds), abnormal fasting blood
glucose, thyroid, renal and hepatic function.

2.3. Test diets
The diets were prepared at the hospital’s kitchen and consisted
of 1200 kcal with 62.3% fat (20% saturated fatty acids), 15% protein,
23% carbohydrate, and 122 mg cholesterol, for a total fat content of
80 g. In both diets, the total fat from walnuts and almonds was kept
the same. The diets consisted of a sandwich with 100 g white
bread, 75 g salami, and 50 g fatty cheese, 125 g fat-rich (10%)
yogurt, and water. Additionally, participants consumed 77 g
almonds (almond diet) or 60 g shelled walnuts (walnut diet).
77 g almond or 60 g shelled walnuts were chosen to match the fat
content in walnuts and almond (76 g fat in each). The unsaturated
fatty acid content of the almond and walnut diets differed: 28.3%
and 15.2% MUFA, and 7.7% and 23.1% PUFA, respectively. Only the
walnut diet contained ALA (5 g). The nutrient composition of the
walnuts and almonds used in the study is listed in Table 1. The
dietary analysis was performed using Nutritionist Pro version 5.0.0
licensed modules Core, Client Management, Food Labeling.

2.2. Study protocol
We conducted a randomized 2-period, crossover, controlledfeeding trial. All the diets were provided. The protocol was
approved by the West Virginia University Institutional Review
Board and the study was conducted in accordance with the
institutional guidelines. Ethic Committee approval number was H22811. All measurements and blood samples were collected in the
vascular laboratory. Between 2 and 6 weeks before testing,
candidates were interviewed over the phone for clinical history,
had an interview with the dietitian and anthropometric and blood
pressure measurements were noted. Participants were individually randomized in a crossover design between 2 diet sequences
(high-fat diet with walnuts or almond nuts) and were studied on
two separate days 2 weeks apart. The experiments were performed
in the afternoon to avoid confounding by the early morning
blunting in endothelial function. On each study day, participants
were asked to eat a low-fat breakfast at 7:00 AM and to refrain from
further food intake until 11:30 AM, when they reported to the
vascular laboratory and had a blood sample taken. Blood pressure
was measured with a standard mercury sphygmomanometer. At
12:00 PM a baseline ultrasound assessment of endothelial function
in the brachial artery was performed after resting for half an hour.
Thereafter, participants ate 1 of the 2 diets under the supervision of
a clinical investigator. The protocol was repeated 4 h postprandially,

2.4. Endothelial function testing
The operator was unaware of diet sequences. Suitable measurements were obtained in all tests. Subjects abstained from tobacco
smoking and coffee. After blood samples had been drawn, subjects
were placed supine at rest for 15 min in a quiet room at normal
room temperature. A continuous ECG was recorded for timing of
measurements. The brachial artery was scanned longitudinally 2–
5 cm above the antecubital crease. This location was marked on the
skin and all subsequent measurements were performed at the
same location. FMD measurement using brachial artery reactivity
testing was performed by 2-dimensional gray-scale and color ﬂow
Doppler vascular imaging by a Philips Sonos 7500 ultrasound
machine (HP, Andover, Massachusetts) with an 11-MHz vascular
ultrasound probe at baseline and after 4 h. Baseline dimensions
were recorded at the center of the vessel with optimal contrast
between the anterior and posterior vessel walls and the lumen.

Table 1
Average fatty acid composition of walnut and almond diets.
Walnut Diet
Whole Diet
Energy, kcal
Fat, g
SFA, g
MUFA, g
18:1, Oleic
PUFA, g
18:2, Linoleic
18:3, Linolenic
Protein, g
Cholesterol, mg
Carbohydrate, g

1128
80
25
19
17.3
29
23.7
5.9
42
122
66

Almond Diet
% Calorie
62.3
19.9
15.2
13.8
23.1
18.9
4.7
14.70
23.10

Walnuts only
392
39
3
5
5
28
22
5
9
0
8

% Calorie
31.1
2.4
3.9
3.9
22.3
17.5
3.9
3.2
2.8

SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids.

Whole Diet
1178
78
24
37
35.6
10
10.1
0.5
49
122
75

% Calorie
58.7
18.3
28.3
27.2
7.6
7.6
16.4
24.8

Almonds only
442
38
2.8
23
9
23
9
0
16
0
16

% Calorie
29
2.1
17.6
6.8
6.9
6.8
5.4
5.4
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Doppler blood ﬂow images were recorded from the center of the
vessel. Then an arterial occlusion cuff, placed above the antecubital
fossa was inﬂated to 300 mmHg for ﬁve minutes. Immediately after
deﬂation of the cuff, a continuous 90 s recording of blood ﬂow and
vessel dimensions were obtained. The peak diameter of the artery
was recorded 60 s after deﬂation of the cuff, and the percentage
change from the baseline diameter was calculated. FMD percent
diameter change was determined as follows: (diameter after
reactive hyperemia 
baseline diameter) &z.urule; baseline
diameter  100. To avoid the confounding effects of arterial
compliance and its cyclic changes in dimensions, all measurements
were obtained at the peak of the R-wave of the electrocardiogram.
The mean diameter of the brachial artery was determined at
baseline, then continuously up to 3 min after reactive hyperemia.
These images were then stored on a digitized system (Camtronics
Medical Systems, Hartland, Wisconsin) that has a caliper with 0.1mm resolution. Average diameters (intima to intima) from 3
cardiac cycles were obtained. Brachial artery diameter measurements were done in a random order and the investigator was
blinded to the experimental condition. Shear rate was calculated
per standard protocol blood ﬂow velocity divided by vessel
diameter.26,27
2.5. Determination of sVCAM levels
For the analysis of soluble vascular cell adhesion molecules
(sVCAM), blood samples were ethylenediamine tetraacetic acid
(EDTA)-treated and centrifuged (2,000g, 15 min, 4  C) immediately
after collection. Plasma was rapidly frozen and stored at 80  C.
After thawing, sVCAM, catalog number DVC00, was quantiﬁed by
ELISA (R & D Systems).

499

3. Results
Of the 27 participants in the study, 16 were women and 11 were
men. Average age of participants was 42.3  6.8 years. The average
BMI of the study population was 28.6  2.2 kg/m2. Clinical
characteristics and parameters of endothelial function of the
study population are presented in Table 2.
3.1. Flow-mediated dilatation
During almond diet intervention, the baseline brachial artery
lumen diameter changed from 3.3  0.18 mm to 3.6  0.16 mm and
the absolute change in diameter was 0.33  0.19 mm. The mean
endothelial function measured as FMD percent change was
10.08  6.7. After intervention, the diameter changed from
3.3  0.17 to 3.7  0.2 mm and the absolute change in diameter
was 0.36  0.2 mm. The mean endothelial function measured as
FMD percent change was 12.4  7.4. The percent change in FMD
pre-and post-intervention was not signiﬁcantly different with p
= 0.06 (Fig. 1). Normalized FMD did not change signiﬁcantly preand post-intervention from 0.18  0.11 to 0.23  0.14, p = 0.08
(Table 2).
Similarly, during walnut diet intervention, the baseline
diameter changed from 3.2  0.16 mm to 3.57  0.15 mm and
the absolute change in diameter was 0.36  0.17 mm. The mean
endothelial function measured as FMD percent change was

2.6. Statistical analyses
Baseline characteristics for the 2 groups were compared using
Student’s t and chi-square tests as appropriate. Signiﬁcance of
changes from baseline to 4 h post-intervention was assessed
separately for the walnut and almond diet groups using matchedpair t-tests. Comparisons of the magnitude and direction of
changes between groups was assessed by an analysis of variance
appropriate to the repeated measures nature of the experimental
design. Changes in FMD and sVCAM were assessed by 2 factors
with repeated measures: period (almond vs. walnut diets) and
time (baseline vs. post-intervention), and all their interactions.
Associations between changes in inﬂammatory marker and risk
factors (age, sex, body mass index) with changes in FMD were
evaluated by partial correlation analyses. Signiﬁcance levels
(p < 0.05) were used for all comparisons. No adjustment for
multiple testing was employed at any point in the analysis.

Fig. 1. FMD% change comparison between walnut and almond groups at baseline
and 4 h after diet. There was signiﬁcant improvement in normalized FMD in the
walnut diet group (p = 0.004). Almond diet group showed an upward trend but did
not reach signiﬁcance.

Table 2
Endothelial function, clinical characteristics of study population:
Almond Diet

FMD (Diameter, mm)
FMD/shear rate
FMD (change%)
AVP (cm/s)
SBP(mm Hg)
DBP(mm Hg)
HR (beats/min)
Biomarker
sVCAM (mg/L)

Walnut Diet

P*value

Baseline

Post Intervention

P† value

Baseline

Post Intervention

Pz value

0.33  0.19
0.18  0.11
10.8  6.7
199  42.7
118  4.6
73  6.8
70  7.2

0.36  0.2
0.23  0.14
12.4  7.4
206  26
116.8  4.5
73.6  6.4
66  8.1

0.11
0.08
0.06
0.23
0.11
0.24
0.58

0.36  0.17
0.2  0.1
11.7  6
183  40.9
119  5
73.7  6
69  6.7

0.52  0.2
0.31  0.1
16.2  5.8
200  38.1
117.9  4.4
72.9  6.8
63  8.3

0.001
0.005
0.004
0.14
0.17
0.36
0.72

0.20
0.36
0.34
0.72
0.67
0.81
0.74

1380  406

1257.7  321

0.004

1400  368

1241  325

0.009

0.51

FMD = Flow mediated dilatation, AVP = Average peak velocity, SBP = Systolic Blood pressure, DBP = Diastolic Blood pressure, HR = Heart rate.
Flow-mediated dilation = absolute change in diameter, P† = p value pre and post almond diet intervention, Pz = p value pre and post walnut diet intervention, P* = p value
between change in almond and walnut intervention. sVCAM-1 = soluble vascular cell adhesion molecule 1.
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11.7  6. After intervention, the diameter changed from
3.23  0.19 to 3.75  0.17 mm and the absolute change in diameter
was 0.52  0.2 mm. The mean endothelial function measured as
FMD percent change was 16.2  5.8. The percent change in
FMD pre-and post-intervention was signiﬁcantly different
with p = 0.004. However, the% change in FMD pre-and postintervention between almond and walnut diet was not signiﬁcant
(p value = 0.34). Normalized FMD also changed signiﬁcantly preand post-intervention from 0.2 to 0.31 (p = 0.005). Inter-observer
variation assessment for brachial artery measurements was
performed in the study participants using a correlation coefﬁcient, and the variation was found to be small (r = 0.94).
3.2. sVCAM
The level of sVCAM decreased signiﬁcantly with the almond
diet from 1380 to 1257 mg/L (p = 0.004). Similarly, the level of
sVCAM decreased signiﬁcantly with the walnut diet from 1400 to
1241 (mg/L), p = 0.009 (Table 2). However, there was no signiﬁcant
difference changes in sVCAM between the almond and walnut
diets (p = 0.51).
Baseline vessel diameter in men and women was not
signiﬁcantly different (3.4  0.17 vs 3.3  0.18 mm, p = 0.36). Partial
correlation analysis was performed between changes in FMD and
changes in other variables (weight, systolic and diastolic blood
pressures, and heart rate), and there was no signiﬁcant relation
seen in these groups. There was a signiﬁcant inverse correlation
between changes in FMD and changes in sVCAM in the walnut diet
group (p = 0.000). This difference was not signiﬁcant in the almond
diet group.
The systolic blood pressure decreased with the almond diet
(118–116.8 mmHg, p = 0.11). A similar change was seen with the
walnut diet (119–117.9 mmHg, p = 0.17). Heart rate decreased with
both almond (70–66 beats/min, p = 0.58) and walnut diets (69–63
beats/min, p = 0.17).
4. Discussion
In this study, there was acute and signiﬁcant improvement in
FMD with both walnut and almond diets. A similar interaction
was seen between sVCAM and the walnut diet. For the almond
diet, the absolute change in diameter was 0.33  0.19 mm
(baseline) and 0.36  0.2 mm (after intervention), p = 0.11. Similarly, for walnut diet, the absolute change in diameter was
0.36  0.17 mm (baseline) and 0.52  0.2 mm (after intervention),
p = 0.001. The FMD percent change with the walnut diet at
baseline was 11.7  6% and 16.2  5.8 after intervention with
p = 0.004. This improvement is consistent with the results of
several studies in the past that have assessed endothelial FMD
after a walnut diet.19–21 Although the FMD percent change tended
to increase with almond diet (10.8  6.7 to 12.4  7.4), the change
was not signiﬁcant (p = 0.06). The FMD percent change between
the almond and walnut diets was not signiﬁcant (p = 0.34).
Similarly, even though the change in normalized FMD with the
walnut diet was signiﬁcant (p = 0.005) and tended to improve
with almond diet (p = 0.08), there was no difference between the
two diets (p = 0.36).
Endothelial dysfunction is a critical event in atherogenesis that
is implicated both in early disease and in advanced atherosclerosis,
where it relates to perfusion abnormalities and the causation of
ischemic events.1,2,5 Disturbed endothelial function can also be
assessed by levels of adhesion molecules like sVCAM-1.28 It has
been postulated that abnormal levels of these molecules are
associated with development of atherosclerosis and increased risk
of major future cardiovascular events.29,30 n-3 PUFA have clearly
demonstrated anti-thrombotic, anti-inﬂammatory and anti-

arrhythmic effects, thus possessing speciﬁc anti-atherosclerotic
properties.31 n-3 PUFA from nuts, mainly ALA in walnuts, may have
a number of cardio protective actions including protection from
fatal coronary heart disease and sudden death due to their antiarrhythmic properties.32,33 De Loregril et al in the Lyon Diet Heart
Study observed that n-3 PUFA provided signiﬁcant protection from
coronary death.34
The role of ALA in reducing inﬂammation is important because
inﬂammatory events are central in the pathogenesis of atherosclerosis.35 Rallidis et al concluded that diets enriched with ALA from
walnuts or other sources reduce circulating levels of cytokines and
other inﬂammatory mediators involved in endothelial activation.36
Several clinical trials have assessed the effect of walnuts and
almonds on VCAM-1 concentration.19,37,38 Perrez-Martinez et al,
using a crossover design, showed an increase in plasma VCAM-1
levels after a western diet compared to a walnut enriched diet,
although no signiﬁcant difference was seen between the olive oil
and walnut diets.37 In our study the walnut diet signiﬁcantly
decreased the sVCAM (p = 0.009). Likewise, the almond diet also
signiﬁcantly decreased the sVCAM (p = 0.004). There was no
signiﬁcant difference between the two diets on sVCAM levels.
These results are in accordance with results from a randomized
controlled cross-over study by Ros et al who showed improvement
in endothelial dependent vasodilation and reduced vascular cell
adhesion molecule-1 levels compared to a Mediterranean control
diet.19
Few studies have evaluated the effects of walnuts or other nuts
on blood pressure, but most of these have found either a beneﬁcial
effect or no effect.39–41 In our study there was no signiﬁcant change
in blood pressure with the walnut or almond diet even though it
tended to decrease in both groups.
5. Conclusion
Both walnut and almond diets improved endothelial function as
seen by signiﬁcant improvement in FMD and another marker of
endothelial dysfunction, the adhesion molecule (sVCAM). However, there were no signiﬁcant differences between the two diets as
regards to FMD and sVCAM. Larger studies with longer follow-ups
are needed to further study the effect of walnut and almond diets
on endothelial function.
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